Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

611 questions in 50 reviews · Injuries

current versions
No studies 125 · 20.5%Ungraded 22 · 3.6%Very low 185 · 30.3%Low 171 · 28%Moderate 77 · 12.6%High 31 · 5.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
DDAVP vs aprotinin
Blood loss (total) · participants undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
no estimate extractedNRNo studies
DDAVP vs aprotinin
All‐cause mortality · participants undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
no estimate extracted1 study · 53 participantsVery low
DDAVP vs aprotinin
All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) · participants undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
0.98 [0.06, 15.89]2 studies · 152 participantsVery low
DDAVP vs aprotinin
Quality of life · participants undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
no estimate extractedNRNo studies
DDAVP vs placebo or standard care
Blood loss (total) · participants undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
no estimate extracted28 studies · 1643 participantsVery low
DDAVP vs placebo or standard care
All‐cause mortality · participants undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
1.09 [0.51, 2.34]22 studies · 1631 participantsLow
DDAVP vs placebo or standard care
All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) · participants undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
1.36 [0.85, 2.16]29 studies · 1984 participantsLow
DDAVP vs placebo or standard care
Quality of life · participants undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
no estimate extractedNRNo studies
DDAVP vs placebo or standard care: platelet dysfunction subgroup
Red cell volume transfused (total) · participants with platelet dysfunction undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
no estimate extracted6 studies · 388 participantsLow
DDAVP vs placebo or standard care: platelet dysfunction subgroup
Number of participants receiving a red cell transfusion (total) · participants with platelet dysfunction undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
RR 0.83 [0.66, 1.04]5 studies · 258 participantsLow
DDAVP vs placebo or standard care: platelet dysfunction subgroup
Blood loss (total) · participants with platelet dysfunction undergoing surgery
Desmopressin use for minimising perioperative blood transfusion (2017) · Cochrane
no estimate extracted7 studies · 422 participantsLow
Cardiorespiratory exercise programmes prescribed alone vs a non‐exercise intervention or no intervention
Cardiorespiratory fitness ‐ peak power output (W) ‐ end of intervention · people with traumatic brain injury of any age or severity
Fitness training for cardiorespiratory conditioning after traumatic brain injury (2017) · Cochrane
no estimate extracted3 studies · 67 participantsLow
Cardiorespiratory exercise programmes prescribed alone vs a non‐exercise intervention or no intervention
Depression ‐ SMD ‐ end of intervention · people with traumatic brain injury of any age or severity
Fitness training for cardiorespiratory conditioning after traumatic brain injury (2017) · Cochrane
no estimate extracted4 studies · 220 participantsVery low
Cardiorespiratory exercise programmes prescribed alone vs a non‐exercise intervention or no intervention
Cognition · people with traumatic brain injury of any age or severity
Fitness training for cardiorespiratory conditioning after traumatic brain injury (2017) · Cochrane
no estimate extracted2 studies · 111 participantsUngraded
Cardiorespiratory exercise programmes prescribed alone vs a non‐exercise intervention or no intervention
Fatigue ‐ SMD ‐ end of intervention · people with traumatic brain injury of any age or severity
Fitness training for cardiorespiratory conditioning after traumatic brain injury (2017) · Cochrane
no estimate extracted3 studies · 130 participantsVery low
Cardiorespiratory exercise programmes prescribed alone vs a non‐exercise intervention or no intervention
Community integration · people with traumatic brain injury of any age or severity
Fitness training for cardiorespiratory conditioning after traumatic brain injury (2017) · Cochrane
no estimate extracted1 study · 76 participantsUngraded
Cardiorespiratory exercise programmes prescribed alone vs a non‐exercise intervention or no intervention
Safety · people with traumatic brain injury of any age or severity
Fitness training for cardiorespiratory conditioning after traumatic brain injury (2017) · Cochrane
no estimate extracted5 studies · 183 participantsUngraded
Baclofen vs placebo
Spasticity at up to 6 hours after treatment (measured by the Ashworth Scale, 0‐, with a higher score indicating greater spasticity) · adults with traumatic brain injury with spasticity in their arms and legs
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted1 study · 11 participantsLow
Botulinum toxin A (with and without casting) vs placebo (with and without casting)
Sensory functions and pain · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Botulinum toxin A (with and without casting) vs placebo (with and without casting)
Neuromusculoskeletal and movement‐related functions at 12 weeks (measured by ankle dorsiflexion) · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted2 studies · 47 participantsVery low
Botulinum toxin A (with and without casting) vs placebo (with and without casting)
General tasks and demands · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Botulinum toxin A (with and without casting) vs placebo (with and without casting)
Mobility · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Botulinum toxin A (with and without casting) vs placebo (with and without casting)
Self‐care · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Pseudoelastic orthosis vs traditional (static) splint
Spasticity at up to 6 hours after treatment (measured by the Modified Ashworth Scale, 0‐4, with a higher score indicating greater spasticity) · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis'…
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted1 study · 25 participantsVery low
Pseudoelastic orthosis vs traditional (static) splint
Adverse events · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis'…
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted1 study · 25 participantsVery low
Pseudoelastic orthosis vs traditional (static) splint
Sensory functions and pain · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis'…
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Pseudoelastic orthosis vs traditional (static) splint
Neuromusculoskeletal and movement‐related functions post treatment (measured by range of movement) · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis'…
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted1 study · 25 participantsVery low
Pseudoelastic orthosis vs traditional (static) splint
General tasks and demands · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis'…
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Baclofen vs placebo
Adverse events · adults with traumatic brain injury with spasticity in their arms and legs
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted1 study · 11 participantsLow
Pseudoelastic orthosis vs traditional (static) splint
Mobility · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis'…
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Pseudoelastic orthosis vs traditional (static) splint
Self‐care · children/young people aged 4‐18 years with traumatic brain injury and with 'mild to severe spastic tetraparesis'…
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Baclofen vs placebo
Sensory functions and pain · adults with traumatic brain injury with spasticity in their arms and legs
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Baclofen vs placebo
Neuromusculoskeletal and movement‐related functions up to 6 hours after treatment (Measured by spasm and deep tendon reflex scores, 0‐5, with 0 being no reflexes and 5 being clonus, or repeated involuntary muscle contractions) · adults with traumatic brain injury with spasticity in their arms and legs
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted1 study · 11 participantsLow
Baclofen vs placebo
General tasks and demands · adults with traumatic brain injury with spasticity in their arms and legs
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Baclofen vs placebo
Mobility · adults with traumatic brain injury with spasticity in their arms and legs
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Baclofen vs placebo
Self‐care · adults with traumatic brain injury with spasticity in their arms and legs
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Botulinum toxin A (with and without casting) vs placebo (with and without casting)
Spasticity at 4‐12 weeks (measured by both Modified Ashworth Scale, 0‐5, at 12 weeks and Tardieu Scale, 0‐5, at 4 weeks) · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted2 studies · 47 participantsVery low
Botulinum toxin A (with and without casting) vs placebo (with and without casting)
Adverse events · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
Interventions for managing skeletal muscle spasticity following traumatic brain injury (2017) · Cochrane
no estimate extracted2 studies · 47 participantsVery low
Intervention NR
Mortality · people with severe traumatic brain injury (adults and children)
Elevation of the head during intensive care management in people with severe traumatic brain injury (2017) · Cochrane
no estimate extracted3 studies · 20 participantsVery low
Intervention NR
Intracranial pressure (ICP) · people with severe traumatic brain injury (adults and children)
Elevation of the head during intensive care management in people with severe traumatic brain injury (2017) · Cochrane
no estimate extracted3 studies · 20 participantsVery low
Intervention NR
Cerebral perfusion pressure (CPP) · people with severe traumatic brain injury (adults and children)
Elevation of the head during intensive care management in people with severe traumatic brain injury (2017) · Cochrane
no estimate extracted3 studies · 20 participantsVery low
Intervention NR
Quality of life; Glasgow Coma Score; Disability · people with severe traumatic brain injury (adults and children)
Elevation of the head during intensive care management in people with severe traumatic brain injury (2017) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events · people with severe traumatic brain injury (adults and children)
Elevation of the head during intensive care management in people with severe traumatic brain injury (2017) · Cochrane
no estimate extracted3 studies · 20 participantsVery low
Intervention NR
Mortality at end of scheduled · people with acute TBI secondary to head injury
Progesterone for acute traumatic brain injury (2016) · Cochrane
RR 0.91 [0.65, 1.28]5 studies · 2376 participantsLow
Intervention NR
Disability (unfavourable outcomes: death, vegetative state, severe disability; GOS 1‐3) at end of scheduled · people with acute TBI secondary to head injury
Progesterone for acute traumatic brain injury (2016) · Cochrane
RR 0.98 [0.89, 1.06]4 studies · 2260 participantsModerate
Intervention NR
Intracranial pressure (ICP) within the treatment period · people with acute TBI secondary to head injury
Progesterone for acute traumatic brain injury (2016) · Cochrane
no estimate extracted3 studies · 3 participantsUngraded
Intervention NR
Blood pressure · people with acute TBI secondary to head injury
Progesterone for acute traumatic brain injury (2016) · Cochrane
no estimate extracted1 study · 1 participantsUngraded
Intervention NR
Body temperature · people with acute TBI secondary to head injury
Progesterone for acute traumatic brain injury (2016) · Cochrane
no estimate extracted1 study · 1 participantsUngraded
Intervention NR
Adverse events · people with acute TBI secondary to head injury
Progesterone for acute traumatic brain injury (2016) · Cochrane
no estimate extracted4 studies · 4 participantsUngraded
School injury prevention programmes vs controls
Self‐reported medically or non‐medically attended unintentional injuries or injuries with an unspecified intent (injury rates adjusted for clustering) · children and young people
School‐based education programmes for the prevention of unintentional injuries in children and young people (2016) · Cochrane
Rate ratio 0.76 [0.49, 1.17]2 studies · 12977 participantsLow